Below is the full task description ONLY REQUIRE a script
Below is the full task description ONLY REQUIRE a script
Length 5 minute speech which I will present once I have a script. No referencing is needed and gramma isnt vital.
Task Description
In this assessment task you are provided with a scenario and relevant patient information.
The patient is Ngarla Kngwarreye. You have met Ngarla in the Intensive 2 workshop. There is more information about her on this module page "Assessment task 3: the person".
You will research and apply clinical reasoning to understand the patient's presentation and then explain the rationale for therapeutic management of this patient.
This individual assignment will require you to submit a5-minute video recordingto demonstrate;
your understanding of this patient's condition and the therapeutic management
your ability to communicate health information to fellow health professionals
Within the task you will be required to use appropriate and accurate discipline specific language.
IN YOUR OWN WORDS, you will need to:
Explain the rationalefor two of the therapeutic approaches for this patient as identified on this module page "Assessment task 3: therapies for discussion".
Relate the therapeutic approachesto the pathophysiological presentation of this patient.
Use appropriate terminologyand communication style.
Assessment criteria and marking rubric
Your submission will be assessed against the following criteria. You are strongly encouraged to review the marking rubric for this assessment task as it provides more detailed information about the assessment criteria.
Assessment Criteria Measures IntendedLearning Outcome:
Criterion 1 Explain the pathophysiological basis for the patients health condition with reference to relevant anatomical structures and physiological processes. ILO1, ILO2 and ILO3
Criterion 2 Explain the rationale for therapeutic approaches. ILO2 and ILO3
Criterion 3 Use appropriate terminology and communication style to explain the patient's health condition and rationale for therapeutic approaches. ILO3
Referencing is not required, however you are required to identify any guidelines which support the therapy/interventions suggested for Ms Kngwarreye.
Consider the person
Ngarla Kngwarreye is a 60 year old Anmatyerre woman from Urapuntja in Central Australia. Some years ago, after a long history of cigarette smoking, she developed chronic obstructive pulmonary disease. Despite her best efforts at quitting, she has not been able to completely stop smoking. Her disease progressed, and she also has cor pulmonale.
Management of her condition now includes the following:
Oxygen therapy: use of an oxygen concentrator at night
Pulmonary rehabilitation: attends the clinic in Alice Springs with the support of nurses from the Central Australia Health service.
Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013)
Medications:
Inhaler: Trelegy (fluticasone fuorate (100 mcg) / umeclidinium (62.5 mcg) / vilanterol (25 mcg)) : 1 inhalation daily
spironolactone 25 mg daily
alendronate 70 mg weekly
calcium carbonate 600 mg x 2 daily
fluoxetine 20 mg daily
Other interventions:
Pneumococcal vaccination
Yearly influenza vaccination
Last week Ms Kngwarreye visited the local school and met with the children to talk about her art. A day or so later, she developed "a bit of a head cold".
Two days ago, Ms Kngwarreye's normal cough increased, and she began producing tenacious green-coloured sputum. The nurses from the community health clinic came to visit her at home and based on her presentation organised transport to Alice Springs Hospital.
At the hospital, a chest x-ray showed that her lungs were hyper-expanded, her diaphragm flattened and a large area of consolidation in her left lung was identified as pneumonia.
Based on her assessment data the following management was commenced:
Oxygen therapy:
BiPAP - 5 cmH2O peak end expiratory pressure / 5 cmH2O pressure support / 10 cmH20 peak inspiratory pressure - FiO228%; 4 hours of therapy
which then changed to
oxygen via high flow nasal prongs delivered in heated, humidified air - 21% FiO2/ 30 L/min titrated to maintain SpO288 92% and a respiratory rate < 24 bpm
Medications:
salbutamol 5mg by nebuliser with air as required
ipratroprium 500mcg by nebuliser with air as required
prednisolone 50mg daily x 5 days
spironolactone 50 mg daily
Therapies for discussion
Context of the presentation:
You have been asked to present Ms Kngwarreye's case to your colleagues as part of an in-service about COPD. Your presentation will focus on the therapies and interventions for the management of Ms Kngwarreye's current condition. In all, you need to chooseTWO (2)therapies / interventionsfrom the lists below, about which you will educate your colleagues.
Your presentation needs to demonstrate that you are speaking to your colleagues IN YOUR OWN WORDS. You can, as you would in an education session such as this, use notes, but you would not read everything from a script.You do NOT need to use PowerPoint.You will be successful with this assessment if you demonstrate that you are explaining concepts, using your own words.
A. From this list chooseONE (1)medication therapy to discuss:
You need to describe the ACTION/S of the medication. You need to identify the AIM of this therapy for Ms Kngwarreye. You need to refer to any GUIDELINES which support the use of this medication for this patient. You need to identifyoneRISK or special consideration for Ms Kngwarreyewhilst taking this medication. You need to identify what evidence will demonstrate the EFFECTIVENESS of this therapy.
salbutamol 5mg by nebuliser with air as required
ipratroprium 500mcg by nebuliser with air as required
prednisolone 50mg daily x 5 days
spironolactone 50 mg daily
B. From this list chooseONE (1)therapeutic intervention to discuss:
You need to identify the AIM of this intervention by discussing the intendedphysiological effects or benefitsspecific to Ms Kngwarreye. You need to refer to any GUIDELINES which support this intervention. As appropriate, you need to identify what evidence will demonstrate the EFFECTIVENESS of this therapy.
oxygen via high flow nasal prongs delivered in heated, humidified air
BiPAP therapy
pulmonary rehabilitation
pneumococcal vaccination and annual influenza vaccination as per schedule
NOTE: If you choose to discuss BiPAP or High flow oxygen therapy, you do NOT need to focus on the rates or levels of the therapy. You need to consider the general principles of this therapy as they apply to Ms Kngwarreye.
